Exane Derivatives’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Exane Derivatives’s Portfolio NGM Stock Details NGM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$154	Sell
2022 Q1	$34.9K	Buy
2021 Q4	$37.3K	Buy
2021 Q3	$1.96K	Sell
2021 Q2	$25.9K	Sell
2021 Q1	$190K	Buy
2020 Q4	$176K	Buy